Events

EU TalentOn second edition
SEP
Mon
09
SEP
Tue
10
SEP
Wed
11
SEP
Thu
12
SEP
Fri
13
SEP
Sat
14

This was 1 year ago

Location

Katowice Poland

University of Silesia (different venues)
Programmes
Health Climate, Energy, Mobility Agro-Food, Environment Enhancing EU R&I Missions

The European Commission in collaboration with Katowice (Poland) as European City of Science in 2024 organises the second edition of EU TalentOn. During EU TalentOn a group of selected researchers between the ages 21 and 35 years old, will work in a team to come up with the best scientific solutions for challenges linked to one of the five EU missions. The contest finale will take place between 9-14 September 2024 in Katowice.

The previous EU TalentOn edition took place in Leiden in 2022 and these were the projects.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.